ALFA FinderNSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹557.00
- Market cap
- ₹1,299 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 23.3×Sector 54.5×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Results Update
Q-Line Biotech's H1 FY27 revenue rose 5.83% while EBITDA grew 10.02%, but PAT fell 8.06%. The release also covers a proposed 70% stake acquisition in Heidelco.
Q-Line Biotech H1 FY27 Results: Net Profit ₹19.6 Cr, Down 8.0% YoY
Q-Line Biotech Ltd reported revenue from operations of ₹152.2 Cr (+5.8% YoY) and net profit of ₹19.6 Cr (-8.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹19.6 Cr · -8.0% YoY
Q-Line Biotech Legal & Regulatory
Q-Line Biotech's board said a Rs.10,000 NSE fine for late XBRL voting-results filing was due to a portal glitch and requested a waiver. The total payable including GST is Rs.11,800.
- Value
- ₹0.01 Cr
Q-Line Biotech Board Meeting Date
Q-Line Biotech clarified a clerical error: its board meeting time is 4:15 PM, not 3:00 PM. The November 12, 2026 meeting will consider half-yearly financial results.
Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Other other announcement announcements
All →Studio LSD Other Announcement
Studio LSD extended the timeline for unutilised IPO proceeds to March 2028 for capex and March 2027 for general purposes. No change to objects or allocated amounts.
S.K. Offset Other Announcement
S. K. Offset appointed Vinay Terse & Associates as Secretarial Auditor and Sanjay & Co. as Internal Auditor for 12 months. Both appointments are routine.
- Execution
- 12 months
Manappuram Finance Other Announcement
Manappuram Finance filed its monitoring agency report for the quarter ended September 30, 2026, covering its preferential issue. Crisil reports no deviation from the issue objects.
Chatterbox Technologies Other Announcement
Chatterbox Technologies filed its IPO monitoring agency report for the quarter ended September 30, 2026. It reports no deviation from objects, though utilisation is delayed against the schedule.
Stanley Lifestyles Other Announcement
Stanley reported no deviation in IPO proceeds use for the quarter ended September 2026. The Reg 32 statement confirms routine utilisation with no change to objects.
Sunshine Pictures Other Announcement
Sunshine Pictures' IPO monitoring agency report for Q2 FY27 flags a Rs.1.44 crore GST deviation from object utilisation. Management says selling shareholders will reimburse it.